NK-cell phenotype at interruption underlies widely divergent duration of CD4+- guided antiretroviral treatment interruption

Federica Bozzano, Milena Nasi, Linda Bertoncelli, Elisa Nemes, Francesca Prati, Francesco Marras, Cristina Mussini, Lorenzo Moretta, Andrea Cossarizza, Andrea de Maria

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Long-term side effects may represent a relevant burden of antiretroviral treatment (ART) in HIV-infected patients with good CD4 immune reconstitution over extended time spans. CD4-guided treatment interruption (TI) has been evaluated to address this point and may result in a wide spectrum of time off ART in different patient cohorts. We studied whether differences in innate immune responses, in particular NK cells, are associated to patterns of longer (LoTI) or a shorter (ShTI) TI. Clinical cohort parameters were analyzed on a group of patients widely diverging for TI duration (18 months) on samples before TI, including NK-cell analysis and function by natural cytotoxicity receptor (NCR)-triggered γ-IFN production. Although persistently reduced NCR expression (NKp30) and function were observed in both LoTI and ShTI patients on ART compared with healthy donors, relevant differences were observed at baseline TI in those patients who subsequently developed LoTI course. Lower expression of NKG2D and NKp46 on NK cells. This also translates in reduced γ-IFN production in redirected functional assays. Thus, differences in innate immune balance exist during ART, may be associated to differential control of HIV infection and their understanding could explain clinical differences in individual patients that are not reflected by CD4+ cell counts alone.

Original languageEnglish
Pages (from-to)109-118
Number of pages10
JournalInternational Immunology
Volume23
Issue number2
DOIs
Publication statusPublished - 2011

Fingerprint

Natural Killer Cells
Phenotype
Therapeutics
Natural Cytotoxicity Triggering Receptor 3
CD4 Lymphocyte Count
Innate Immunity
Individuality
HIV Infections
Tissue Donors
HIV

Keywords

  • Antiretroviral treatment
  • CD4
  • HIV
  • NCR
  • NK cells
  • Treatment interruption

ASJC Scopus subject areas

  • Immunology

Cite this

NK-cell phenotype at interruption underlies widely divergent duration of CD4+- guided antiretroviral treatment interruption. / Bozzano, Federica; Nasi, Milena; Bertoncelli, Linda; Nemes, Elisa; Prati, Francesca; Marras, Francesco; Mussini, Cristina; Moretta, Lorenzo; Cossarizza, Andrea; de Maria, Andrea.

In: International Immunology, Vol. 23, No. 2, 2011, p. 109-118.

Research output: Contribution to journalArticle

Bozzano, Federica ; Nasi, Milena ; Bertoncelli, Linda ; Nemes, Elisa ; Prati, Francesca ; Marras, Francesco ; Mussini, Cristina ; Moretta, Lorenzo ; Cossarizza, Andrea ; de Maria, Andrea. / NK-cell phenotype at interruption underlies widely divergent duration of CD4+- guided antiretroviral treatment interruption. In: International Immunology. 2011 ; Vol. 23, No. 2. pp. 109-118.
@article{ec0a78dcdb204e2bbd7b990392c482bc,
title = "NK-cell phenotype at interruption underlies widely divergent duration of CD4+- guided antiretroviral treatment interruption",
abstract = "Long-term side effects may represent a relevant burden of antiretroviral treatment (ART) in HIV-infected patients with good CD4 immune reconstitution over extended time spans. CD4-guided treatment interruption (TI) has been evaluated to address this point and may result in a wide spectrum of time off ART in different patient cohorts. We studied whether differences in innate immune responses, in particular NK cells, are associated to patterns of longer (LoTI) or a shorter (ShTI) TI. Clinical cohort parameters were analyzed on a group of patients widely diverging for TI duration (18 months) on samples before TI, including NK-cell analysis and function by natural cytotoxicity receptor (NCR)-triggered γ-IFN production. Although persistently reduced NCR expression (NKp30) and function were observed in both LoTI and ShTI patients on ART compared with healthy donors, relevant differences were observed at baseline TI in those patients who subsequently developed LoTI course. Lower expression of NKG2D and NKp46 on NK cells. This also translates in reduced γ-IFN production in redirected functional assays. Thus, differences in innate immune balance exist during ART, may be associated to differential control of HIV infection and their understanding could explain clinical differences in individual patients that are not reflected by CD4+ cell counts alone.",
keywords = "Antiretroviral treatment, CD4, HIV, NCR, NK cells, Treatment interruption",
author = "Federica Bozzano and Milena Nasi and Linda Bertoncelli and Elisa Nemes and Francesca Prati and Francesco Marras and Cristina Mussini and Lorenzo Moretta and Andrea Cossarizza and {de Maria}, Andrea",
year = "2011",
doi = "10.1093/intimm/dxq462",
language = "English",
volume = "23",
pages = "109--118",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - NK-cell phenotype at interruption underlies widely divergent duration of CD4+- guided antiretroviral treatment interruption

AU - Bozzano, Federica

AU - Nasi, Milena

AU - Bertoncelli, Linda

AU - Nemes, Elisa

AU - Prati, Francesca

AU - Marras, Francesco

AU - Mussini, Cristina

AU - Moretta, Lorenzo

AU - Cossarizza, Andrea

AU - de Maria, Andrea

PY - 2011

Y1 - 2011

N2 - Long-term side effects may represent a relevant burden of antiretroviral treatment (ART) in HIV-infected patients with good CD4 immune reconstitution over extended time spans. CD4-guided treatment interruption (TI) has been evaluated to address this point and may result in a wide spectrum of time off ART in different patient cohorts. We studied whether differences in innate immune responses, in particular NK cells, are associated to patterns of longer (LoTI) or a shorter (ShTI) TI. Clinical cohort parameters were analyzed on a group of patients widely diverging for TI duration (18 months) on samples before TI, including NK-cell analysis and function by natural cytotoxicity receptor (NCR)-triggered γ-IFN production. Although persistently reduced NCR expression (NKp30) and function were observed in both LoTI and ShTI patients on ART compared with healthy donors, relevant differences were observed at baseline TI in those patients who subsequently developed LoTI course. Lower expression of NKG2D and NKp46 on NK cells. This also translates in reduced γ-IFN production in redirected functional assays. Thus, differences in innate immune balance exist during ART, may be associated to differential control of HIV infection and their understanding could explain clinical differences in individual patients that are not reflected by CD4+ cell counts alone.

AB - Long-term side effects may represent a relevant burden of antiretroviral treatment (ART) in HIV-infected patients with good CD4 immune reconstitution over extended time spans. CD4-guided treatment interruption (TI) has been evaluated to address this point and may result in a wide spectrum of time off ART in different patient cohorts. We studied whether differences in innate immune responses, in particular NK cells, are associated to patterns of longer (LoTI) or a shorter (ShTI) TI. Clinical cohort parameters were analyzed on a group of patients widely diverging for TI duration (18 months) on samples before TI, including NK-cell analysis and function by natural cytotoxicity receptor (NCR)-triggered γ-IFN production. Although persistently reduced NCR expression (NKp30) and function were observed in both LoTI and ShTI patients on ART compared with healthy donors, relevant differences were observed at baseline TI in those patients who subsequently developed LoTI course. Lower expression of NKG2D and NKp46 on NK cells. This also translates in reduced γ-IFN production in redirected functional assays. Thus, differences in innate immune balance exist during ART, may be associated to differential control of HIV infection and their understanding could explain clinical differences in individual patients that are not reflected by CD4+ cell counts alone.

KW - Antiretroviral treatment

KW - CD4

KW - HIV

KW - NCR

KW - NK cells

KW - Treatment interruption

UR - http://www.scopus.com/inward/record.url?scp=79551650527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551650527&partnerID=8YFLogxK

U2 - 10.1093/intimm/dxq462

DO - 10.1093/intimm/dxq462

M3 - Article

C2 - 21216830

AN - SCOPUS:79551650527

VL - 23

SP - 109

EP - 118

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 2

ER -